A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors

Clinical trial NCT02366312 · COMPLETED

Trial details

NCT number: NCT02366312
Sponsor: NYU College of Dentistry
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Keratocystic Odontogenic Tumor

Start date: 2015-10-27
Primary completion: 2019-08-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.